Stock Events

Stock Events

Uluru 

$0
2
+$0+0% Tuesday 15:32

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
30.57
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

15NovExpected
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
0
0.33
0.67
1
Expected EPS
0
Actual EPS
0

Financials

-270.01%Profit Margin
Unprofitable
2012
2013
2014
2015
2016
2017
717,000Revenue
-1.94MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ULUR. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its subsidiaries, develops and sells a wide range of healthcare products, overlapping with Uluru's wound care and biotechnology products.
Pfizer
PFE
Mkt Cap149.77B
Pfizer Inc. operates in the biopharmaceutical industry producing medicines and vaccines, directly competing in the healthcare sector similar to Uluru.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. is a global healthcare company that offers health solutions, including wound care and management, which competes with Uluru's product offerings.
Abbott Laboratories
ABT
Mkt Cap155.82B
Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, competing in similar markets as Uluru.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol-Myers Squibb Company, a biopharmaceutical company, develops and markets drugs in areas overlapping with Uluru's therapeutic sectors.
Lilly(Eli) &
LLY
Mkt Cap862.01B
Eli Lilly and Company focuses on pharmaceutical products and has initiatives in biomedicine, directly competing with some of Uluru's biotechnological advancements.
GSK
GSK
Mkt Cap103.01B
GlaxoSmithKline plc is a healthcare company that researches and develops pharmaceuticals, vaccines, and health-related consumer products, competing in the same industry as Uluru.
Novartis
NVS
Mkt Cap279.67B
Novartis AG provides healthcare solutions that compete with Uluru in terms of pharmaceuticals and biotechnological research in healthcare.
Sanofi
SNY
Mkt Cap110.4B
Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions, competing with Uluru in the pharmaceutical and biotech sectors.
Astrazeneca
AZN
Mkt Cap286.4B
AstraZeneca PLC, a biopharmaceutical company, develops products in various therapy areas that are similar to Uluru's, making it a direct competitor.

About

Pharmaceuticals: Other
Health Technology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
Show more...
CEO
Country
United States
ISIN
US90403T3086

Listings

0 Comments

Share your thoughts

FAQ

What is Uluru stock price today?▼
The current price of ULUR is $0 USD — it has increased by +0% in the past 24 hours. Watch Uluru stock price performance more closely on the chart.
What is Uluru stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Uluru stocks are traded under the ticker ULUR.
What is Uluru market cap?▼
Today Uluru has the market capitalization of 30.57
What were Uluru earnings last quarter?▼
ULUR earnings for the last quarter are 0 USD per share, whereas the estimation was 0 USD resulting in a +NaN% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Uluru revenue for the last year?▼
Uluru revenue for the last year amounts to 717,000 USD.
What is Uluru net income for the last year?▼
ULUR net income for the last year is -1.94M USD.
In which sector is Uluru located?▼
Uluru operates in the Other sector.
When did Uluru complete a stock split?▼
The last stock split for Uluru was on March 23, 2020 with a ratio of 1000:1.